This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
International Agency for Research on Cancer. World cancer report 2014. Stewart B, Wild CP, editors, World Health Organization; 2014.International Agency for Research on CancerWorld cancer report 2014StewartBWildCPWorld Health Organization2014Search in Google Scholar
Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B. Survival of cancer patients, diagnosed in 1991-2005 in Slovenia. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.Primic-ŽakeljMZadnikVŽagarTZakotnikBSurvival of cancer patients, diagnosed in 1991-2005 in SloveniaLjubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia2009Search in Google Scholar
Cancer incidence in Slovenia 2001. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2004.Cancer incidence in Slovenia 2001Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia2004Search in Google Scholar
Cancer in Slovenia 2010. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2013.Cancer in Slovenia 2010Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2013Search in Google Scholar
Cancer in Slovenia 2012. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2015.Cancer in Slovenia 2012Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2015Search in Google Scholar
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015; 385: 977-1010.AllemaniCWeirHKCarreiraHHarewoodRSpikaDWangXSGlobal surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Lancet2015385977101010.1016/S0140-6736(14)62038-9Search in Google Scholar
Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER cancer statistics review, 1975-2005. Bethesda: National Cancer Institute.RiesLAGMelbertDKrapchoMStinchcombDGHowladerNHornerMJSEER cancer statistics review 1975-2005BethesdaNational Cancer InstituteSearch in Google Scholar
Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Colorectal cancer. Lancet 2005; 365: 153-65.WeitzJKochMDebusJHöhlerTGallePRBüchlerMWColorectal cancerLancet20053651536510.1016/S0140-6736(05)17706-XSearch in Google Scholar
Kanthan R, Senger JL, Kanthan SC. Molecular events in primary and meta-static colorectal carcinoma: a review. Patholog Res Int 2012; 2012: 597497.KanthanRSengerJLKanthanSCMolecular events in primary and meta-static colorectal carcinoma: a reviewPatholog Res Int20122012597497Search in Google Scholar
Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-8.IacopettaBAre there two sides to colorectal cancer?Int J Cancer2002101403810.1002/ijc.1063512216066Search in Google Scholar
Benson AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22: 3408-19.BensonABSchragDSomerfieldMRCohenAMFigueredoATFlynnPJAmerican Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancerJ Clin Oncol20042234081910.1200/JCO.2004.05.06315199089Search in Google Scholar
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw 2009; 7: 778-831.EngstromPFArnolettiJPBensonABChenYJChotiMACooperHSNCCN Clinical Practice Guidelines in Oncology: colon cancerJ Natl Compr Canc Netw2009777883110.6004/jnccn.2009.005619755046Search in Google Scholar
Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, Group EGW. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2010; 21(Suppl 5): v70-7.LabiancaRNordlingerBBerettaGDBrouquetACervantesAGroup EGWPrimary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-upAnn Oncol201021Suppl 570710.1093/annonc/mdq16820555107Search in Google Scholar
Freeman HJ. Early stage colon cancer. World J Gastroenterol 2013; 19: 8468-73.FreemanHJEarly stage colon cancerWorld J Gastroenterol20131984687310.3748/wjg.v19.i46.8468387049224379564Search in Google Scholar
Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ. Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 2007; 9: 563-71.NicastriDGDoucetteJTGodfreyTEHughesSJIs occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literatureJ Mol Diagn200795637110.2353/jmoldx.2007.070032204905217916603Search in Google Scholar
Mitchell PJ, Ravi S, Grifftiths B, Reid F, Speake D, Midgley C, et al. Multicentre review of lymph node harvest in colorectal cancer: are we understaging colorectal cancer patients? Int J Colorectal Dis 2009; 24: 915-21.MitchellPJRaviSGrifftithsBReidFSpeakeDMidgleyCMulticentre review of lymph node harvest in colorectal cancer: are we understaging colorectal cancer patients?Int J Colorectal Dis2009249152110.1007/s00384-009-0697-z19387664Search in Google Scholar
Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA. Molecular staging individualizing cancer management. J Surg Oncol 2012; 105: 468-74.MejiaASchulzSHyslopTWeinbergDSWaldmanSAMolecular staging individualizing cancer managementJ Surg Oncol20121054687410.1002/jso.21858331280222441898Search in Google Scholar
Kang BW, Jeon HS, Chae YS, Lee SJ, Park JY, Choi JE, et al. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer. PLoS One 2015; 10: e0119649.KangBWJeonHSChaeYSLeeSJParkJYChoiJEAssociation between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancerPLoS One201510e011964910.1371/journal.pone.0119649437089225799222Search in Google Scholar
Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling MK, et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 2007; 9: 862-70.KollmarORupertusKScheuerCJunkerBTiltonBSchillingMKStromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasisNeoplasia200798627010.1593/neo.07559204021317971906Search in Google Scholar
Koskensalo S, Louhimo J, Nordling S, Hagström J, Haglund C. MMP-7 as a prognostic marker in colorectal cancer. Tumour Biol 2011; 32: 259-64.KoskensaloSLouhimoJNordlingSHagströmJHaglundCMMP-7 as a prognostic marker in colorectal cancerTumour Biol2011322596410.1007/s13277-010-0080-221207220Search in Google Scholar
Kanzaki H, Ouchida M, Hanafusa H, Sakai A, Yamamoto H, Suzuki H, et al. Single nucleotide polymorphism in the RAD18 gene and risk of colorectal cancer in the Japanese population. Oncol Rep 2007; 18: 1171-5.KanzakiHOuchidaMHanafusaHSakaiAYamamotoHSuzukiHSingle nucleotide polymorphism in the RAD18 gene and risk of colorectal cancer in the Japanese populationOncol Rep20071811715Search in Google Scholar
Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-MET signalling, predicts colon cancer metastasis. Nat Med 2009; 15: 59-67.SteinUWaltherWArltFSchwabeHSmithJFichtnerIMACC1, a newly identified key regulator of HGF-MET signalling, predicts colon cancer metastasisNat Med200915596710.1038/nm.188919098908Search in Google Scholar
Ting L, Jun H, Junjie C. RAD18 lives a double life: Its implication in DNA double-strand break repair. DNA Repair (Amst) 2010; 9: 1241-8.TingLJunHJunjieCRAD18 lives a double life: Its implication in DNA double-strand break repairDNA Repair (Amst)201091241810.1016/j.dnarep.2010.09.01620971043Search in Google Scholar
Pan J, Chi P, Lu X, Xu Z. Genetic polymorphisms in translesion synthesis genes are associated with colorectal cancer risk and metastasis in Han Chinese. Gene 2012; 504: 151-5.PanJChiPLuXXuZGenetic polymorphisms in translesion synthesis genes are associated with colorectal cancer risk and metastasis in Han ChineseGene2012504151510.1016/j.gene.2012.05.04222652275Search in Google Scholar
Cañadas I, Taus A, González I, Villanueva X, Gimeno J, Pijuan L, et al. High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients. Oncotarget 2014; 5: 5246-56.CañadasITausAGonzálezIVillanuevaXGimenoJPijuanLHigh circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patientsOncotarget2014552465610.18632/oncotarget.2124417059525026301Search in Google Scholar
Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 2009; 41: 2356-9.ArltFSteinUColon cancer metastasis: MACC1 and Met as metastatic pacemakersInt J Biochem Cell Biol2009412356910.1016/j.biocel.2009.08.00119666136Search in Google Scholar
Lang AH, Geller-Rhomberg S, Winder T, Stark N, Gasser K, Hartmann B, et al. A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients. BMC Cancer 2012; 12: 20.LangAHGeller-RhombergSWinderTStarkNGasserKHartmannBA common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patientsBMC Cancer2012122010.1186/1471-2407-12-20328263522251819Search in Google Scholar
Muendlein A, Hubalek M, Geller-Rhomberg S, Gasser K, Winder T, Drexel H, et al. Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients. Eur J Cancer 2014; 50: 2134-41.MuendleinAHubalekMGeller-RhombergSGasserKWinderTDrexelHSignificant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patientsEur J Cancer20145021344110.1016/j.ejca.2014.05.00724910416Search in Google Scholar
Dziki L, Przybyłowska K, Majsterek I, Trzciński R, Mik M, Sygut A. A/G polymorphism of the MMP-7 gene promoter region in colorectal cancer. Pol Przegl Chir 2011; 83: 622-6.DzikiLPrzybyłowskaKMajsterekITrzcińskiRMikMSygutAA/G polymorphism of the MMP-7 gene promoter region in colorectal cancerPol Przegl Chir201183622610.2478/v10035-011-0098-122246095Search in Google Scholar
Wieczorek E, Reszka E, Wasowicz W, Grzegorczyk A, Konecki T, Sosnowski M, et al. MMP7 and MMP8 genetic polymorphisms in bladder cancer patients. Cent European J Urol 2014; 66: 405-10.WieczorekEReszkaEWasowiczWGrzegorczykAKoneckiTSosnowskiMMMP7 and MMP8 genetic polymorphisms in bladder cancer patientsCent European J Urol2014664051010.5173/ceju.2013.04.art3399244224757528Search in Google Scholar
Peng B, Cao L, Ma X, Wang W, Wang D, Yu L. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis 2010; 25: 371-9.PengBCaoLMaXWangWWangDYuLMeta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer riskMutagenesis201025371910.1093/mutage/geq01520360147Search in Google Scholar
Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai H, et al. Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Int J Cancer 2009; 124: 208-14.Beeghly-FadielAShuXOLongJLiCCaiQCaiHGenetic polymorphisms in the MMP-7 gene and breast cancer survivalInt J Cancer20091242081410.1002/ijc.23859259769818798254Search in Google Scholar
Chernov AV, Sounni NE, Remacle AG, Strongin AY. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. J Biol Chem 2009; 284: 12727-34.ChernovAVSounniNERemacleAGStronginAYEpigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cellsJ Biol Chem2009284127273410.1074/jbc.M900273200267600219286653Search in Google Scholar
Matsusue R, Kubo H, Hisamori S, Okoshi K, Takagi H, Hida K, et al. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 2009; 16: 2645-53.MatsusueRKuboHHisamoriSOkoshiKTakagiHHidaKHepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axisAnn Surg Oncol20091626455310.1245/s10434-009-0599-x19588204Search in Google Scholar
Coelho A, Calçada C, Catarino R, Pinto D, Fonseca G, Medeiros R. CXCL12-3’ A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy? Cancer Immunol Immunother 2006; 55: 639-43.CoelhoACalçadaCCatarinoRPintoDFonsecaGMedeirosRCXCL12-3’ A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy?Cancer Immunol Immunother2006556394310.1007/s00262-005-0062-116155757Search in Google Scholar
Dommange F, Cartron G, Espanel C, Gallay N, Domenech J, Benboubker L, et al. CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia. FASEB J 2006; 20: 1913-5.DommangeFCartronGEspanelCGallayNDomenechJBenboubkerLCXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemiaFASEB J2006201913510.1096/fj.05-5667fje16818471Search in Google Scholar
Chang SC, Lin PC, Yang SH, Wang HS, Li AF, Lin JK. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol 2009; 16: 2323-30.ChangSCLinPCYangSHWangHSLiAFLinJKSDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancerAnn Surg Oncol20091623233010.1245/s10434-009-0501-x19472013Search in Google Scholar
Schmoll HJ, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trial. J Clin Oncol 2015; 33: 3733-40.SchmollHJTaberneroJMarounJde BraudFPriceTVan CutsemECapecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trialJ Clin Oncol20153337334010.1200/JCO.2015.60.910726324362Search in Google Scholar
André T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol 2015; 33: 4176-87.AndréTde GramontAVernereyDChibaudelBBonnetainFTijeras-RaballandAAdjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC studyJ Clin Oncol20153341768710.1200/JCO.2015.63.4238Search in Google Scholar
Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370: 2020-9.GrayRBarnwellJMcConkeyCHillsRKWilliamsNSKerrDJAdjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised studyLancet20073702020910.1016/S0140-6736(07)61866-2Search in Google Scholar
Inese D, Ilze S, Andrejs V, Janis G. Frequency of morphologic prognostic factors in surgically treated colorectal cancer. Acta Chirurgica Latvensis 2014; 14: 3-8.IneseDIlzeSAndrejsVJanisGFrequency of morphologic prognostic factors in surgically treated colorectal cancerActa Chirurgica Latvensis2014143810.2478/chilat-2014-0101Search in Google Scholar
Zhang B, Lv M, Chen T, Wei Q, Wang G, Tian J, et al. The association between lymph node resection and postoperative survival in patients with colorectal cancer. Hepatogastroenterology 2013; 60: 1922-6.ZhangBLvMChenTWeiQWangGTianJThe association between lymph node resection and postoperative survival in patients with colorectal cancerHepatogastroenterology20136019226Search in Google Scholar
Ratto C, Sofo L, Ippoliti M, Merico M, Bossola M, Vecchio FM, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 1999; 42: 143-54; Discussion 154-48.RattoCSofoLIppolitiMMericoMBossolaMVecchioFMAccurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significanceDis Colon Rectum199942143541544810.1007/BF0223711910211489Search in Google Scholar
Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 2009; 27: 5131-7.LiebigCAyalaGWilksJVerstovsekGLiuHAgarwalNPerineural invasion is an independent predictor of outcome in colorectal cancerJ Clin Oncol2009275131710.1200/JCO.2009.22.4949277347219738119Search in Google Scholar
Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 2012; 118: 628-38.BetgeJPollheimerMJLindtnerRAKornpratPSchlemmerARehakPIntramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reportingCancer20121186283810.1002/cncr.2631021751188Search in Google Scholar
